Pasithea Therapeutics warrants set to expire Sept. 17, 2026
Pasithea Therapeutics said its Nasdaq-listed warrants will expire on September 17, 2026 and be delisted.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.